Thomson Pharma ® KOLexperts is a sophisticated system that helps users objectively identify, verify, develop, and understand key opinion leaders, scientific experts, product advocates, and clinical investigators. The system was specifically designed with advanced tools to help those with responsibilities in marketing functions as well as discovery, research, clinical, medical science liaison, and medical affairs functions across the Pharmaceutical, and Biotechnology Industry.
Thomson Pharma KOLexperts is a premier tool supporting the pharmaceutical, and biotechnology industry that gives users the ability to objectively identify, rank and verify KOLs and scientific experts in the life sciences.
With Thomson Pharma KOLexperts, you can:
Marketing and Commercialization:
- Offers the objectivity you need — using this system you can search for and view the experts in a therapy area of interest, and determine a scientist’s ranking at a glance. This ranking system objectively identifies the scientists recognized as truly “driving the science” in any given field or therapeutic area, discriminating these leaders from many hundreds of others working in the field worldwide and also helps identifying the rising stars.
- Helps you pinpoint credible KOLs — identify KOLs who can help you create a surge of influence and market focused attention before, during, and after product launch
- Makes tracking of KOLs easier — cited work, research activity, speaking engagements and other promotional or educational efforts are all factors utilized in the system
- Uncover emerging KOLs — helps identify the rising stars
- Target geographies – find KOLs in the countries or regions that align with your marketing and advocacy goals
Research & Discovery:
- Make better decisions faster — systematically identify the scientists recognized as truly driving the science in any given field or therapeutic area, and discriminate these leaders from many hundreds of experts in the field worldwide to facilitate results in an expedient manner
- Form collaborative research partnerships — identify scientist that may collaborate with you and fill in any research gaps you may have and expedite the clinic trial process
- Develop drugs quicker — get the best scientific guidance and input into your research and development programs at the earliest possible juncture
- Collaborate with experts — whether you are publishing an article or developing a proof of concept you can pinpoint the best candidate to work with
Why choose Thomson Pharma KOLexperts?
Our system brings together core respected databases of Thomson Reuters as well as key external data sources. Thomson Reuters' history in this area goes as far back as 1955, when Dr. Eugene Garfield revolutionized scientific research with his concept of citation indexing and searching. Content is expertly indexed, editorially-maintained, and up-to-date. Whether you are looking for an expert in early development for collaboration, a thought leader to support your product, or a speaker for an up coming meeting you can easily rank experts based on selected criteria and view profiles of the experts in your therapy areas of interest, and determine a scientist’s ranking at a glance. It is a Who’s Who — from discovery to market that utilizes trusted data that lowers your risks.
- Proprietary Thomson Reuters data sources — Using proprietary Thomson Reuters data allows you to get a view on who is the most highly cited author, inventor or speaker allowing you a unique view into who is making the biggest impact.
- Integrated search tools — view, rank, compare, analyze, print, and export individual or multiple profiles and profile data
- Filtering and ranking tools — filter your therapy areas to reflect your own unique view of your research and rank leaders according to your individual needs
- Accurate, and reliable data — features validated key demographic and scientific expertise data that identifies a recognized expert in one or more research fields
- Flexible infrastructure — an underlying generic data acquisition/editorial process can be extended to capture data from new or customer-specific areas
- Enterprise analysis — manipulate the profile data searches to meet your needs using tools and technologies that allow the database to be searched in flexible ways according to multiple criteria to identify groups of scientists fitting a required set of criteria
- Scientific methodology — A proprietary, adjustable algorithm is used which will allow profile data to be scored objectively
- Curated data — Specialized editorial processes are used for each specific therapy area to ensure the true experts are identified (disambiguation) and the most important information is captured and deduplicated.
- Compliant — Complies with all relevant data protection laws
- Easy to employ — Web-browser based user interface, industry standard database, XML-based data
- Export functionality — Easily export the information you need into Excel, Word and PDF formats
- Seamless linking — Access related Thomson Reuters subscriptions (Example literature and citation information in Web of Science)
- Customizable — It will be possible to customize the product components and set-up feeds in XML
Objectively identifying key opinion leaders (KOLs), scientific experts or clinical investigators can be an onerous task. In this white paper, Thomson Reuters identifies the key issues and proposes a solution for optimal KOL identification and selection.
Subscribe to our latest white paper, Key Opinion Leader Identification and Selection, to receive your complimentary copy.
Contact Us
Americas
Tel: +1 800.336.4474
Tel: +1 215.386.0100
Fax: +1 215.386.2911
Europe, Middle East & Africa
Tel: +44 20.7433.4000
Japan
Tel: +81 3.5218.6500
Tel: 0800 888.8855 (free dial from Japan only)
Fax: +81 3.5218.7840
Asia Pacific
Tel: +65 6411.6888
Fax: +65 6223.2634
Next Steps
- More Pharmaceutical & Biotechnology Solutions
- Factsheet PDF
- 10 Ways to Influence the Market PDF
- Request a Demo
- Product Inquiries
